;PMID: 7865834
;source_file_2965.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:43..141] = [t:43..141]
;2)section:[e:145..168] = [t:145..168]
;3)section:[e:172..258] = [t:172..258]
;4)sentence:[e:262..361] = [t:262..361]
;5)sentence:[e:362..468] = [t:362..468]
;6)sentence:[e:469..649] = [t:469..649]
;7)sentence:[e:650..842] = [t:650..842]
;8)sentence:[e:843..968] = [t:843..968]
;9)sentence:[e:969..1081] = [t:969..1081]
;10)sentence:[e:1082..1249] = [t:1082..1249]
;11)sentence:[e:1250..1480] = [t:1250..1480]
;12)section:[e:1484..1528] = [t:1484..1528]

;section 0 Span:0..37
;Chin Med Sci J.  1994 Sep;9(3):152-6.
(SEC
  (FRAG (NNP:[0..4] Chin) (NNP:[5..8] Med) (NNP:[9..12] Sci) (NNP:[13..15] J.)
        (CD:[17..21] 1994) (CC:[22..28] Sep;9-LRB-) (CD:[28..29] 3)
        (-RRB-:[29..30] -RRB-) (CD:[30..37] :152-6.)))

;sentence 1 Span:43..141
;Down-regulation of c-myc oncogene during NGF-induced differentiation of 
;neuroblastoma cell lines.
;[62..67]:gene-rna:"c-myc"
;[84..87]:gene-protein:"NGF"
;[116..129]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP (RB:[43..47] Down) (HYPH:[47..48] -) (NN:[48..58] regulation))
    (PP (IN:[59..61] of)
      (NP (NN:[62..67] c-myc) (NN:[68..76] oncogene)))
    (PP-TMP (IN:[77..83] during)
      (NP
        (NP
          (ADJP (NN:[84..87] NGF) (HYPH:[87..88] -) (VBN:[88..95] induced))
          (NN:[96..111] differentiation))
        (PP (IN:[112..114] of)
          (NP (NN:[116..129] neuroblastoma) (NN:[130..134] cell)
              (NNS:[135..140] lines)))))
    (.:[140..141] .)))

;section 2 Span:145..168
;Chen J, Liu T, Ross AH.
(SEC
  (FRAG (NNP:[145..149] Chen) (NNP:[150..152] J,) (NNP:[153..156] Liu)
        (NNP:[157..158] T) (,:[158..159] ,) (NNP:[160..164] Ross)
        (NNP:[165..167] AH) (.:[167..168] .)))

;section 3 Span:172..258
;Department of Pathology, Peking Union Medical College Hospital, CAMS & PUMC, 
;Beijing.
(SEC
  (FRAG (NNP:[172..182] Department) (IN:[183..185] of)
        (NNP:[186..195] Pathology) (,:[195..196] ,) (NNP:[197..203] Peking)
        (NNP:[204..209] Union) (NNP:[210..217] Medical) (NNP:[218..225] College)
        (NNP:[226..234] Hospital) (,:[234..235] ,) (NNP:[236..240] CAMS)
        (CC:[241..242] &) (NNP:[243..247] PUMC) (,:[247..248] ,)
        (NNP:[250..257] Beijing) (.:[257..258] .)))

;sentence 4 Span:262..361
;There may be a close relationship between myc oncogenes and carcinogenesis of
; human neuroblastoma.
;[304..307]:gene-rna:"myc"
;[347..360]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (EX:[262..267] There))
    (VP (MD:[268..271] may)
      (VP (VB:[272..274] be)
        (NP-PRD
          (NP (DT:[275..276] a) (JJ:[277..282] close)
              (NN:[283..295] relationship))
          (PP (IN:[296..303] between)
            (NP
              (NP (NN:[304..307] myc) (NNS:[308..317] oncogenes))
              (CC:[318..321] and)
              (NP
                (NP (NN:[322..336] carcinogenesis))
                (PP (IN:[337..339] of)
                  (NP (JJ:[341..346] human) (NN:[347..360] neuroblastoma)))))))))
    (.:[360..361] .)))

;sentence 5 Span:362..468
;In previous studies, we were able to induce differentiation  of certain
;neuroblastoma cell lines with NGF.
;[434..447]:malignancy-type:"neuroblastoma"
;[464..467]:gene-protein:"NGF"
(SENT
  (S
    (PP (IN:[362..364] In)
      (NP (JJ:[365..373] previous) (NNS:[374..381] studies)))
    (,:[381..382] ,)
    (NP-SBJ (PRP:[383..385] we))
    (VP (VBD:[386..390] were)
      (ADJP-PRD (JJ:[391..395] able)
        (VP (TO:[396..398] to)
          (VP (VB:[399..405] induce)
            (NP
              (NP (NN:[406..421] differentiation))
              (PP (IN:[423..425] of)
                (NP
                  (NP (JJ:[426..433] certain) (NN:[434..447] neuroblastoma)
                      (NN:[448..452] cell) (NNS:[453..458] lines))
                  (PP (IN:[459..463] with)
                    (NP (NN:[464..467] NGF))))))))))
    (.:[467..468] .)))

;sentence 6 Span:469..649
;In order to study gene regulation  during differentiation, N-myc and c-myc
;cDNA probes were hybridized with RNA  extracted from different cell lines
;before and after NGF treatment.
;[528..533]:gene-rna:"N-myc"
;[538..543]:gene-rna:"c-myc"
;[635..638]:gene-protein:"NGF"
(SENT
  (S
    (SBAR-ADV (IN:[469..471] In) (NN:[472..477] order)
      (S
        (NP-SBJ (-NONE-:[477..477] *))
        (VP (TO:[478..480] to)
          (VP (VB:[481..486] study)
            (NP (NN:[487..491] gene) (NN:[492..502] regulation))
            (PP-TMP (IN:[504..510] during)
              (NP (NN:[511..526] differentiation)))))))
    (,:[526..527] ,)
    (NP-SBJ-2
      (NP (NN:[528..533] N-myc)
        (NML-1 (-NONE-:[533..533] *P*)))
      (CC:[534..537] and)
      (NP (NN:[538..543] c-myc)
        (NML-1 (NN:[544..548] cDNA) (NNS:[549..555] probes))))
    (VP (VBD:[556..560] were)
      (VP (VBN:[561..571] hybridized)
        (NP-2 (-NONE-:[571..571] *))
        (PP (IN:[572..576] with)
          (NP
            (NP (NN:[577..580] RNA))
            (VP (VBN:[582..591] extracted)
              (NP (-NONE-:[591..591] *))
              (PP (IN:[592..596] from)
                (NP (JJ:[597..606] different) (NN:[607..611] cell)
                    (NNS:[612..617] lines)))
              (PP (IN:[618..624] before) (CC:[625..628] and)
                  (IN:[629..634] after)
                (NP (NN:[635..638] NGF) (NN:[639..648] treatment))))))))
    (.:[648..649] .)))

;sentence 7 Span:650..842
;It was found  that cell lines which expressed N-myc did not express c-myc
;while those with  c-myc did not express N-myc except for SHEP cell line which
;had neither c-myc  nor N-myc expression.
;[696..701]:gene-rna:"N-myc"
;[718..723]:gene-rna:"c-myc"
;[742..747]:gene-rna:"c-myc"
;[764..769]:gene-rna:"N-myc"
;[814..819]:gene-rna:"c-myc"
;[825..830]:gene-rna:"N-myc"
(SENT
  (S
    (NP-SBJ-1
      (NP (PRP:[650..652] It))
      (SBAR-2 (-NONE-:[652..652] *ICH*)))
    (VP (VBD:[653..656] was)
      (VP (VBN:[657..662] found)
        (NP-1 (-NONE-:[662..662] *))
        (SBAR-2 (IN:[664..668] that)
          (S
            (NP-SBJ
              (NP (NN:[669..673] cell) (NNS:[674..679] lines))
              (SBAR
                (WHNP-3 (WDT:[680..685] which))
                (S
                  (NP-SBJ-3 (-NONE-:[685..685] *T*))
                  (VP (VBD:[686..695] expressed)
                    (NP (NN:[696..701] N-myc))))))
            (VP (VBD:[702..705] did) (RB:[706..709] not)
              (VP (VB:[710..717] express)
                (NP (NN:[718..723] c-myc))
                (SBAR-ADV (IN:[724..729] while)
                  (S
                    (NP-SBJ
                      (NP (DT:[730..735] those))
                      (PP (IN:[736..740] with)
                        (NP (NN:[742..747] c-myc))))
                    (VP (VBD:[748..751] did) (RB:[752..755] not)
                      (VP (VB:[756..763] express)
                        (NP (NN:[764..769] N-myc))
                        (PP (IN:[770..776] except)
                          (PP (IN:[777..780] for)
                            (NP
                              (NP (NN:[781..785] SHEP) (NN:[786..790] cell)
                                  (NN:[791..795] line))
                              (SBAR
                                (WHNP-4 (WDT:[796..801] which))
                                (S
                                  (NP-SBJ-4 (-NONE-:[801..801] *T*))
                                  (VP (VBD:[802..805] had)
                                    (NP (CC:[806..813] neither)
                                      (NP (NN:[814..819] c-myc)
                                        (NML-5 (-NONE-:[819..819] *P*)))
                                      (CC:[821..824] nor)
                                      (NP (NN:[825..830] N-myc)
                                        (NML-5 (NN:[831..841] expression))))))))))))))))))))
    (.:[841..842] .)))

;sentence 8 Span:843..968
;In NGF-induced differentiated neuroblastoma cells, c-myc  oncogene was
;down-regulated in comparison with the control samples.
;[846..849]:gene-protein:"NGF"
;[873..886]:malignancy-type:"neuroblastoma"
;[894..899]:gene-rna:"c-myc"
(SENT
  (S
    (PP (IN:[843..845] In)
      (NP
        (ADJP (NN:[846..849] NGF) (HYPH:[849..850] -) (VBN:[850..857] induced))
        (VBN:[858..872] differentiated) (NN:[873..886] neuroblastoma)
         (NNS:[887..892] cells)))
    (,:[892..893] ,)
    (NP-SBJ-1 (NN:[894..899] c-myc) (NN:[901..909] oncogene))
    (VP (VBD:[910..913] was)
      (VP (RB:[914..918] down) (HYPH:[918..919] -) (VBN:[919..928] regulated)
        (NP-1 (-NONE-:[928..928] *))
        (PP (IN:[929..931] in)
          (NP
            (NP (NN:[932..942] comparison))
            (PP (IN:[943..947] with)
              (NP (DT:[948..951] the) (NN:[952..959] control)
                  (NNS:[960..967] samples)))))))
    (.:[967..968] .)))

;sentence 9 Span:969..1081
;The time  course of c-myc down-regulation was concomitant with the appearance
;of  morphological differentiation.
;[989..994]:gene-rna:"c-myc"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[969..972] The) (NN:[973..977] time) (NN:[979..985] course))
      (PP (IN:[986..988] of)
        (NP (NN:[989..994] c-myc) (RB:[995..999] down) (HYPH:[999..1000] -)
            (NN:[1000..1010] regulation))))
    (VP (VBD:[1011..1014] was)
      (ADJP-PRD (JJ:[1015..1026] concomitant)
        (PP (IN:[1027..1031] with)
          (NP
            (NP (DT:[1032..1035] the) (NN:[1036..1046] appearance))
            (PP (IN:[1047..1049] of)
              (NP (JJ:[1051..1064] morphological)
                  (NN:[1065..1080] differentiation)))))))
    (.:[1080..1081] .)))

;sentence 10 Span:1082..1249
;In situ hybridization also showed remarkable  reduction of c-myc oncogene
;expression in NGF-induced differentiated cells as  compared with the
;untreated control cells.
;[1141..1146]:gene-rna:"c-myc"
;[1170..1173]:gene-protein:"NGF"
(SENT
  (S
    (NP-SBJ
      (ADJP (FW:[1082..1084] In) (FW:[1085..1089] situ))
      (NN:[1090..1103] hybridization))
    (ADVP (RB:[1104..1108] also))
    (VP (VBD:[1109..1115] showed)
      (NP
        (NP (JJ:[1116..1126] remarkable) (NN:[1128..1137] reduction))
        (PP (IN:[1138..1140] of)
          (NP (NN:[1141..1146] c-myc) (NN:[1147..1155] oncogene)
              (NN:[1156..1166] expression))))
      (PP-LOC (IN:[1167..1169] in)
        (NP
          (ADJP (NN:[1170..1173] NGF) (HYPH:[1173..1174] -)
                (VBN:[1174..1181] induced))
          (VBN:[1182..1196] differentiated) (NNS:[1197..1202] cells)))
      (SBAR-ADV (IN:[1203..1205] as)
        (S
          (NP-SBJ-1 (-NONE-:[1205..1205] *))
          (VP (VBN:[1207..1215] compared)
            (NP-1 (-NONE-:[1215..1215] *))
            (PP-CLR (IN:[1216..1220] with)
              (NP (DT:[1221..1224] the) (JJ:[1225..1234] untreated)
                  (NN:[1235..1242] control) (NNS:[1243..1248] cells)))))))
    (.:[1248..1249] .)))

;sentence 11 Span:1250..1480
;These results indicate that  down-regulation of c-myc oncogene may be a key
;event during NGF-induced  differentiation and over-expression of c-myc
;oncogene may, at least partially,  be responsible for the genesis of
;neuroblastoma.
;[1298..1303]:gene-rna:"c-myc"
;[1339..1342]:gene-protein:"NGF"
;[1391..1396]:gene-rna:"c-myc"
;[1466..1479]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (DT:[1250..1255] These) (NNS:[1256..1263] results))
    (VP (VBP:[1264..1272] indicate)
      (SBAR (IN:[1273..1277] that)
        (S
          (S
            (NP-SBJ
              (NP (RB:[1279..1283] down) (HYPH:[1283..1284] -)
                  (NN:[1284..1294] regulation))
              (PP (IN:[1295..1297] of)
                (NP (NN:[1298..1303] c-myc) (NN:[1304..1312] oncogene))))
            (VP (MD:[1313..1316] may)
              (VP (VB:[1317..1319] be)
                (NP-PRD
                  (NP (DT:[1320..1321] a) (JJ:[1322..1325] key)
                      (NN:[1326..1331] event))
                  (PP (IN:[1332..1338] during)
                    (NP
                      (ADJP (NN:[1339..1342] NGF) (HYPH:[1342..1343] -)
                            (VBN:[1343..1350] induced))
                      (NN:[1352..1367] differentiation)))))))
          (CC:[1368..1371] and)
          (S
            (NP-SBJ
              (NP (AFX:[1372..1376] over) (HYPH:[1376..1377] -)
                  (NN:[1377..1387] expression))
              (PP (IN:[1388..1390] of)
                (NP (NN:[1391..1396] c-myc) (NN:[1397..1405] oncogene))))
            (VP (MD:[1406..1409] may) (,:[1409..1410] ,)
              (ADVP
                (ADVP (IN:[1411..1413] at) (JJS:[1414..1419] least))
                (RB:[1420..1429] partially))
              (,:[1429..1430] ,)
              (VP (VB:[1432..1434] be)
                (ADJP-PRD (JJ:[1435..1446] responsible)
                  (PP (IN:[1447..1450] for)
                    (NP
                      (NP (DT:[1451..1454] the) (NN:[1455..1462] genesis))
                      (PP (IN:[1463..1465] of)
                        (NP (NN:[1466..1479] neuroblastoma))))))))))))
    (.:[1479..1480] .)))

;section 12 Span:1484..1528
;PMID: 7865834 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1484..1488] PMID) (::[1488..1489] :) (CD:[1490..1497] 7865834)
        (NN:[1498..1499] -LSB-) (NNP:[1499..1505] PubMed) (::[1506..1507] -)
        (NN:[1508..1515] indexed) (IN:[1516..1519] for)
        (NNP:[1520..1528] MEDLINE-RSB-)))
